JUPITER NEUROSCIENCES, INC.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2024 and 2023
BALANCE SHEETS
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash | $3,769,510 | $28,478 |
| Prepaid contracts | 766,667 | - |
| Prepaid and Other current assets | 114,086 | 261 |
| Total current assets | 4,650,263 | 28,739 |
| Operating lease right of use asset, net | 69,642 | 116,070 |
| Prepaid contract, less current portion | 1,478,721 | |
| Other current assets | 3,783 | 3,783 |
| Total assets | $6,202,409 | $148,592 |
| Liabilities and Stockholders’ Equity (Deficit) | ||
| Current Liabilities: | ||
| Accounts payable and accrued expenses | $396,483 | $546,014 |
| Accrued compensation | 1,415,093 | 1,562,041 |
| Accrued interest | 1,064 | 88,000 |
| Current portion of operating lease liability | 50,082 | 48,213 |
| Convertible notes payable, net of discount of $0 | - | 1,638,760 |
| Notes payable, related parties | 146,432 | 383,479 |
| Derivative liability | - | 1,505,398 |
| Total current liabilities | 2,009,154 | 5,771,905 |
| Convertible notes payable, net of discount of $0 and $43,288 | - | 106,712 |
| Operating lease liability, net of current portion | 21,247 | 71,329 |
| Total liabilities | 2,030,401 | 5,949,946 |
| Commitments and Contingencies (Note 8) | - | - |
| Stockholders’ Equity (Deficit): | ||
| Series A preferred stock, par value $0.0001; 5,000,000 shares authorized, nil shares issued and outstanding | - | - |
| Common stock, par value $0.0001; 125,000,000 shares authorized; 33,103,860 and 26,526,405 issued and outstanding | 3,310 | 2,652 |
| Additional paid in capital | 30,190,827 | 17,778,498 |
| Accumulated deficit | (26,022,129) | (23,582,504) |
| Total stockholders’ equity (deficit) | 4,172,008 | (5,801,354) |
| Total liabilities and stockholders’ equity (deficit) | $6,202,409 | $148,592 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.